[1]M.Jin,F.Yang,I.Yang,Y.Yin,J.J.Luo,H.Wang，X.F.Yang,Uric acid,hyperuricemia and vascular diseases,FRONT BIOSCI-LANDMRK,17(2012)656-69.[2]马伊雯,陈海冰,不同人群的尿酸排泄现状及尿酸排泄增加的研究进展,医学研究杂志,47(2018)162-165.[3]X.Liu,Y.Qiu,D.Li,J.Tan,X.Liang,W.Qin,Effectiveness of Drug Treatments for Lowering Uric Acid on Renal Function in Patients With Chronic Kidney Disease and Hyperuricemia:A Network Meta-Analysis of Randomized Controlled Trials,FRONT PHARMACOL,12(2021)690557.[4] H.anai,H.Adachi,M.Hakoshima,H.Katsuyama,Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome,Cardiovascular Diseases and Chronic Kidney Disease,INT J MOL SCI,22(2021).[5]S.Wang,L.Zhang,D.Hao,L.Wang,J.Liu,Q.Niu,L.Mi,X.Peng,J. Gao,Research progress of risk factors and early diagnostic biomarkers of gout-induced renal injury, FRONT IMMUNOL,13(2022)908517.[6]A.Srivastava,A.D.Kaze,C.J.McMullan,T.Isakova,S.S.Waikar,Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD,AM J KIDNEY DIS,71(2018)362-370.[7]T.H.Lin,J.Pajarinen,L.Lu,A.Nabeshima,L.A.Cordova,Z.Yao,S.B.Goodman,NF-kappaB as a Therapeutic Target in Inflammatory-Associated Bone Diseases,ADV PROTEIN CHEM STR,107(2017)117-154.[8]E.Latz,T.S.Xiao,A.Stutz,Activation and regulation of the inflammasomes,NAT REV IMMUNOL,13(2013)397-411.[9]Z.Meng,Y.Yan,Z. Tang,C.Guo,N.Li,W.Huang,G.Ding,Z.Wang,W.Xiao,Z.Yang,Anti-hyperuricemic and nephroprotective effects of rhein in hyperuricemic mice,PLANTA MED,81(2015)279-85.[10]L.Chen,Z.Lan,Polydatin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation by inhibiting NF-kappaB/NLRP3 inflammasome activation via the AMPK/SIRT1 pathway,FOOD FUNCT,8(2017)1785-1792.[11]L.Chen,Z.Lan,Q.Lin,X.Mi,Y.He,L.Wei,Y. Lin,Y.Zhang,X.Deng,Polydatin ameliorates renal injury by attenuating oxidative stress-related infla[14]白莉,魏湘萍,李宁,张晓萍,刘广运,苗明三,牡丹花总黄酮对痛风性肾病小鼠模型的肾脏保护作用,中药药理与临床,38(2022)90-94.[15]白莉,刘广运,张晓萍,苗明三,牡丹花总黄酮对高尿酸血症大鼠降尿酸作用,中国实验方剂学杂志,28(2022)38-45.[16]周蓓蓓,刘萃,李长贵,付正菊,褐藻多糖对大鼠尿酸性肾病的影响,青岛大学医学院学报,52(2016)64-67+70.[17]Y.Zhang,X.Tan,Z.Lin,F.Li,C.Yang,H.Zheng,L.Li,H.Liu,J.Shang,Fucoidan from Laminaria japonica Inhibits Expression of GLUT9 and URAT1 via PI3K/Akt,JNK and NF-kappaB Pathways in Uric Acid-Exposed HK-2 Cells,MAR DRUGS,19(2021).[18] H.Lu,H.Yao,R.Zou,X.Chen,H.Xu,Galangin Suppresses Renal Inflammation via the Inhibition of NF-kappaB,PI3K/AKT and NLRP3 in Uric Acid Treated NRK-52E Tubular Epithelial Cells,BIOMED RES INT,2019(2019)3018357.[19]赵宏,柴桂芳,刘颖斐,李洋,肖洪彬,匡海学,车前子水煎液对痛风性肾病大鼠的肾保护作用及机制,中国实验方剂学杂志,24(2018)108-114.[20]苏筠霞,李建华,刘天喜,肖祖容,刘明龙,魏玉辉,萆薢水提物对尿酸性肾病大鼠TNF-α、MCP-1和ICAM-1表达的影响,中成药,35(2013)1088-1091.[21]R.WANG,C.MA,F.ZHOU,L.KONG,Siwu decoction attenuates oxonate-induced hyperuricemia and kidney inflammation in mice,CHIN J NAT MEDICINES,14(2016)499-507.[22]江雪纯,平凡,张谨枫,汪悦,萆薢除痹汤对大鼠尿酸性肾病防治作用的影响,中国实验方剂学杂志,22(2016)103-108.[23]伍新林,刘利华,刘桃丽,万建新,谢红波,李俊彪,张瑜,化湿泄浊祛瘀汤对尿酸性肾病大鼠肾组织MCP-1、IL-1β表达的影响,中药材,38(2015)1705-1709.[24]C.H.Ma,L.L.Kang,H.M.Ren,D.M.Zhang,L.D.Kong, Simiao pill ameliorates renal glomerular injury via increasing Sirt1 expression and suppressing NF-kappaB/NLRP3 inflammasome activation in high fructose-fed rats,J ETHNOPHARMACOL,172(2015)108-17.[25] Y.Yang,D.M.Zhang,J.H.Liu,L.S.Hu, Q.C.Xue,X.Q，Ding,L.D.Kong,Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice,J ETHNOPHARMACOL, 169(2015)49-59.[26]金文敏,孙治华,秦飞,右归饮对痛风性肾病大鼠活性氧/核因子-κB信号通路的调节及肾脏保护作用研究,中国中西医结合肾病杂志,22(2021)106-110+189.[27]J.Hu,H.Wu,D.Wang,Z.Yang,L.Zhuang,N.Yang,J.Dong,Weicao capsule ameliorates renal injury through increasing autophagy and NLRP3 degradation in UAN rats,INT J BIOCHEM CELL B,96(2018)1-8.[28]王毅兴,吴燕升,张春燕,高建东,降尿酸复方对高尿酸血症大鼠氧化应激及肾脏炎症状态的影响,上海中医药大学学报,32(2018)80-85.[29]隋淑梅,徐梅秀,肾康降酸颗粒对尿酸性肾病大鼠肾组织TNF-α、TGF-β_1表达的影响,中医药信息,28(2011)20-22.
